Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
23.71
-0.31 (-1.29%)
May 21, 2026, 3:00 PM CST
SHA:600196 Market Cap
SHA:600196 has a market cap or net worth of 57.97 billion as of May 21, 2026. Its market cap has increased by 0.81% in one year.
Market Cap
57.97B
Enterprise Value
96.73B
Revenue
42.31B
Ranking
n/a
PE Ratio
18.10
Stock Price
23.71
Market Cap Chart
Since August 9, 2005, SHA:600196's market cap has increased from 4.38B to 57.97B, an increase of 1,224.67%. That is a compound annual growth rate of 13.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 57.97B | -10.95% |
| Dec 31, 2025 | 65.10B | 8.95% |
| Dec 31, 2024 | 59.75B | -2.99% |
| Dec 29, 2023 | 61.59B | -29.14% |
| Dec 30, 2022 | 86.92B | -23.66% |
| Dec 31, 2021 | 113.86B | -9.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 101.99B |
| Zhejiang NHU Company | 97.11B |
| Yunnan Baiyao Group Co.,Ltd | 90.78B |
| Huadong Medicine | 52.84B |
| China Resources Sanjiu Medical & Pharmaceutical | 41.51B |
| Shenzhen Salubris Pharmaceuticals | 40.45B |
| Beijing Tongrentang | 36.07B |
| Changchun High-Tech Industry (Group) | 33.19B |